Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Improvement In Long-Term Survival From Abdominal Aortic Aneurysm Repair
Long-term survival for patients undergoing surgical repair of intact abdominal aortic aneurysms has improved in recent decades, according to a Swedish study reported in Circulation: Journal of the American Heart Association.
generic viagra online
NIH Deepens Investment In Combination Study Of MS Drugs
The first large-scale "CombiRX" clinical trial testing the combined use of FDA-approved interferon beta-1a (Avonex®) and glatiramer acetate (Copaxone®) to treat relapsing-remitting MS has just received a $19-million renewal grant from the National Institutes of Health. This is the largest MS trial ever supported by the NIH, with a cumulative investment of more than $44 million. The long-term trial is led by principal investigator Fred Lublin, MD, (Corinne Goldsmith Dickinson Multiple Sclerosis Center at Mount Sinai School of Medicine, New York, NY).
News of the day
Provectus Reports Encouraging Clinical Data At ASCO On Treatment Of Metastatic Melanoma With PV-10
Provectus Pharmaceuticals, Inc. (OTC Bulletin Board: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has announced interim data from the first 40 subjects in its Phase 2 clinical trial for the treatment of metastatic melanoma. PV-10 treatment was well tolerated and caused selective tumor destruction in the majority of subjects. Additional data on untreated tumors corroborated observations of a possible bystander effect seen during earlier Phase 1 testing. These data were presented today at the American Society of Clinical Oncology 2009 Annual Meeting, Abstract #9060, entitled "Chemoablation of melanoma with intralesional rose bengal (PV-10)," in the General Poster Session.
Medical Devices

Drinkaware's Response To Public Health Commission Report About Health Messages, UK

In response to a report by the Public Health Commission which says health messages need greater clarity and consistency to help people make the right choices, Chris Sorek, Chief Executive of Drinkaware, says: "When it comes to messages about health and alcohol in particular, it"s important that people have the information they need to make the decisions that are right for them. Alcohol can be enjoyed in moderation as part of a healthy lifestyle, but without even realising, many people drink to harmful levels. Sometimes people struggle to know how much is too much, or even to understand the wider impact alcohol misuse can have on their lives - so the first big step towards tackling alcohol misuse is to make sure people have the facts. "Drinkaware provides consumers with the information they need to enjoy alcohol as part of a healthy lifestyle - advising men to stick to 3-4 units a day and women to stick to 2-3 units a day to avoid serious health conditions such as liver disease, some cancers and depression. People can keep track of how much they"re drinking with the Drinkaware unit calculator by visiting http://www.drinkaware.co.uk/tips-and-tools/drink-diary." Drinkaware


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009